In patients with liver cirrhosis the contribution of inherited and acquired prothrombotic disorders in the development of non-malignant portal vein thrombosis (PVT) is inconclusive. The purpose of this retrospective study was to examine the prevalence of thrombophilia in this setting at our center from January 2012 to November 2019. Tests included gene mutational analysis for Factor V Leiden, prothrombin G20210A, (V617F), Calreticulin (), in addition to activated protein C resistance, antithrombin III, protein C and S levels, and antiphospholipid antibodies.
View Article and Find Full Text PDF